MIRRA ANDREEVA WINS FRENCH OPEN AT 19, BECOMES YOUNGEST WOMEN’S CHAMPION SINCE MONICA SELES . (PHOTO).

Image
 Mirra Andreeva wins French Open at 19, becomes youngest women’s champion since Monica Seles   Russian tennis star Mirra Andreeva completed a breakout run at the French Open on Saturday, defeating Polish qualifier Maja Chwalinska 6-3, 6-2 to capture her first Grand Slam title at age 19. Andreeva, who was already regarded as a prodigy after emerging on the WTA Tour as a teenager, became the youngest women’s singles champion since Monica Seles, who was 18 when she won her third straight French Open in 1992. Ranked eighth in the world, she controlled the final in Paris, taking command after dropping just a few early games. The match shifted decisively when Andreeva won nine consecutive games to seize control, eventually closing out the victory with a backhand winner on match point before falling to her knees in celebration on the clay. She finished with 25 winners compared to Chwalinska’s 10 and committed fewer unforced errors in a match played under windy conditions at Cour...

WHO STATEMENT ON ASTRAZENECA COVID-19 VACCINE SAFETY SIGNALS.{PHOTO}.#PRESS RELEASE.

 

Some countries in the European Union have temporarily suspended use of the AstraZeneca COVID-19 vaccine as a precautionary measure based on reports of rare blood coagulation disorders in persons who had received the vaccine. Other countries in the EU – having considered the same information - have decided to continue using the vaccine in their immunization programmes.
Vaccination against COVID-19 will not reduce illness or deaths from other causes. Thromboembolic events are known to occur frequently. Venous thromboembolism is the third most common cardiovascular disease globally.
In extensive vaccination campaigns, it is routine for countries to signal potential adverse events following immunization. This does not necessarily mean that the events are linked to vaccination itself, but it is good practice to investigate them. It also shows that the surveillance system works and that effective controls are in place.
WHO is in regular contact with the European Medicines Agency and regulators around the world for the latest information on COVID-19 vaccine safety. The WHO Global Advisory Committee on Vaccine Safety is carefully assessing the latest available safety data for the AstraZeneca vaccine. Once that review is completed, WHO will immediately communicate the findings to the public.
At this time, WHO considers that the benefits of the AstraZeneca vaccine outweigh its risks and recommends that vaccinations continue.
May be an image of text that says "World Health Organization"

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).